Intellectual Property Watch is an independent news source covering international IP law and policy
Explore its archives, which span from 2005-2019, with the menu above or the link below.
Or, explore our updates on WIPO Committees, beginning in 2006.
A range of practitioners and representatives in the manufacture of medicines, intergovernmental officials, academics and civil society representatives last week gave diverse views on the effectiveness of a waiver to international trade rules intended to ease shipments of affordable medicines…
Results of recent research on the impact of digital rights management (DRM) on the ability of users to take advantage of certain exceptions to copyright have introduced new systemic empirical data into the debate.
CARB-X, an initiative aimed at accelerating innovation in antibacterial treatment, today announced an award to a company to accelerate development of a new bioengineered antimicrobial intended to be applied directly to affected tissues. This follows an announcement earlier this month…
Developing countries would do well to demand a place at the table as negotiations for an Anti-Counterfeiting Trade Agreement undermine the multilateral approach to intellectual property policy making, argues Michael Geist.
Launched in 2018, Health Policy Watch built on IPW’s independent and expert policy reporting on health and IP and expanded its focus to wider health policy issues.
